Form 8-K - Current report:
SEC Accession No. 0001104659-25-002312
Filing Date
2025-01-10
Accepted
2025-01-10 08:32:35
Documents
38
Period of Report
2025-01-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm252819d1_8k.htm   iXBRL 8-K 47551
2 EXHIBIT 99.1 tm252819d1_ex99-1.htm EX-99.1 20849
3 EXHIBIT 99.2 tm252819d1_ex99-2.htm EX-99.2 10879
4 EXHIBIT 99.3 tm252819d1_ex99-3.htm EX-99.3 37894
8 GRAPHIC tm252819d1_ex99-3img001.jpg GRAPHIC 482971
9 GRAPHIC tm252819d1_ex99-3img002.jpg GRAPHIC 707982
10 GRAPHIC tm252819d1_ex99-3img003.jpg GRAPHIC 243113
11 GRAPHIC tm252819d1_ex99-3img004.jpg GRAPHIC 633578
12 GRAPHIC tm252819d1_ex99-3img005.jpg GRAPHIC 455417
13 GRAPHIC tm252819d1_ex99-3img006.jpg GRAPHIC 599139
14 GRAPHIC tm252819d1_ex99-3img007.jpg GRAPHIC 221481
15 GRAPHIC tm252819d1_ex99-3img008.jpg GRAPHIC 575354
16 GRAPHIC tm252819d1_ex99-3img009.jpg GRAPHIC 552522
17 GRAPHIC tm252819d1_ex99-3img010.jpg GRAPHIC 635827
18 GRAPHIC tm252819d1_ex99-3img011.jpg GRAPHIC 216527
19 GRAPHIC tm252819d1_ex99-3img012.jpg GRAPHIC 531778
20 GRAPHIC tm252819d1_ex99-3img013.jpg GRAPHIC 405952
21 GRAPHIC tm252819d1_ex99-3img014.jpg GRAPHIC 215837
22 GRAPHIC tm252819d1_ex99-3img015.jpg GRAPHIC 445861
23 GRAPHIC tm252819d1_ex99-3img016.jpg GRAPHIC 383891
24 GRAPHIC tm252819d1_ex99-3img017.jpg GRAPHIC 497427
25 GRAPHIC tm252819d1_ex99-3img018.jpg GRAPHIC 439583
26 GRAPHIC tm252819d1_ex99-3img019.jpg GRAPHIC 645734
27 GRAPHIC tm252819d1_ex99-3img020.jpg GRAPHIC 437830
28 GRAPHIC tm252819d1_ex99-3img021.jpg GRAPHIC 188070
29 GRAPHIC tm252819d1_ex99-3img022.jpg GRAPHIC 471447
  Complete submission text file 0001104659-25-002312.txt   14003198

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA mrsn-20250110.xsd EX-101.SCH 3012
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrsn-20250110_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrsn-20250110_pre.xml EX-101.PRE 22357
40 EXTRACTED XBRL INSTANCE DOCUMENT tm252819d1_8k_htm.xml XML 3557
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 25520591
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)